The Global Extracorporeal Shock Wave Therapy Device Market is expected to grow at a CAGR of 5.2% during the forecasting period (2020-2027).
The extracorporeal shock wave therapy device is an electronic device used to produce low-energy sound waves that interact directly through a gel medium with an individual’s affected area. As it can be used in orthopedics, physiotherapy, urology, sports drugs, veterinary medicines, rehabilitation centers, plastic surgery and others, shockwave therapy has multidisciplinary usage. It is a non-surgical procedure for treating soft tissue injuries, chronic pain and the reparative phase of affected bones and tendons.
The major factors propelling the growth of the extracorporeal shock wave therapy device market are the growing demand for hassle-free techniques and the rise in the prevalence of arthritis and musculoskeletal disorders. Moreover, a rise in the incidence of chronic muscular & tendon disorders, back & neck pains coupled with sports injuries is expected to robust the market’s growth. The global market for extracorporeal shock wave therapy products increases in demand, mostly due to the substantial growth in medical industry R&D activities. The rising prevalence of bone disorders among senior citizens, such as arthritis, raises the need for extracorporeal shock wave therapy equipment for knee problems. Furthermore, technical developments such as integrating laser technology with a shock wave system are fueling the market’s growth.
Demand for Hassle-Free Techniques is Driving the Market Growth
The growth of the global shock wave therapy system industry is driven by advances in research and development activities, increased use of modern equipment in hospitals and clinics, and improved medications. Because of the demand for technologically advanced treatment methods, the market is expected to record substantial growth. In the geriatric population, the growing prevalence of bone diseases provides an impetus for business development. The device for shock wave therapy also helps increase cellular activity in the body, which further aids the development of the industry of shock wave therapy devices.
Table-top portable ESWT
Hand-push type ESWT
Based on geography, the study analyzes the Extracorporeal Shock Wave Therapy Device market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
North America is expected to dominate the global Extracorporeal Shock Wave Therapy Device market.
North America is controlling and contributing the leading shares to the global market for shock wave therapy devices in terms of sales. It is expected to report substantial growth over a forecast period due to the growing demand for alternative treatment for minor surgeries in the area, such as shock wave therapy devices. Europe also contributed modest shares and reported a healthy growth rate, led by North America, in the global market for shock wave therapy equipment. Additionally, Due to the growing prevalence of geriatric population and bone injuries in Asia Pacific countries such as India and China, the Asia Pacific has become the lucrative market for shock wave therapy devices and is projected to register significant shares over the forecast period.
The Extracorporeal Shock Wave Therapy Device market is highly competitive, owing to big food brands’ presence. The key Extracorporeal Shock Wave Therapy Device players contributing to the growth of the global market include Share Co. Ltd., BTL, Starz Medical, EMS Electro Medical Systems, MTS Medical, Zimmer MedizinSystem, GYMNA, LIKAMED GMBH, INCELER MEDIKAL, HANIL-TM and HNT MEDICAL, among others. The major players are adopting new product launch and expansion strategies for global growth in the Extracorporeal Shock Wave Therapy Device market.
Sai Kiran Sales Manager at DataM Intelligence Email: firstname.lastname@example.org Tel: +1 877 441 4866 Website: www.datamintelligence.com
Menafn, Reportedtimes, PR-Wirein, Extended Distribution, Research Newswire, English
Sales Manager at DataM Intelligence
Tel: +1 877 441 4866